Today, on World COPD Day, we are excited to share the results of the HOT-HMV trial presented at ERS, which show that HMV added to HOT can reduce by 51% the likelihood of readmissions to hospital or death over one year in hypercapnic COPD patients following an acute exacerbation of COPD.1 There are new prospects for better treatment of COPD—and better lives for patients.
Evidence has shown improved outcomes when non-invasive ventilation is added to a COPD treatment program.1-3
ResMed offers you intelligent non-invasive ventilation solutions that can help you tailor treatment to the unique and changing needs of your patients. From ventilators and masks to oxygen options and accessories, ResMed’s solutions work together to help patients breathe easier as they manage their condition.
Our solutions are “intelligent” because they allow you to choose the most appropriate product combination to suit your individual COPD patient’s needs, and provide automatically-adjusting therapy as their condition progresses, for even more personalisation.
You can do this with:
* World Health Organization. “Chronic respiratory diseases: Burden of COPD” Who.int. https://www.who.int/data/gho/publications/world-health-statistics (accessed November 9, 2015)